Notable Upgrades: Clovis Oncology (CLVS), Diana Shipping (DSX), Cameco (CCJ), HSBC Holdings (HSBC), Oramed (ORMP)

Analysts at Goldman Sacsh (GS) are out with a report this morning upgrading shares of Clovis Oncology, Inc. (CLVS) with a ‘Buy‘ from ‘Neutral‘ rating. CLVS shares recently gained $9.86 to $87.26. In the past 52 weeks, shares of Boulder, Colorado-based biopharmaceutical company have traded between a low of $35.33 and a high of $89.98 […] View the full post at: Notable Upgrades: Clovis Oncology (CLVS), Diana Shipping (DSX), Cameco (CCJ), HSBC Holdings (HSBC), Oramed (ORMP) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock